HCW Biologics (NASDAQ:HCWB) reported quarterly losses of $(0.08) per share. This is a 73.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported $394.80 thousand in sales this quarter. This is a 70.18 percent decrease over sales of $1.32 million the same period last year.